Promising bladder combo study pulled before it began
NCT ID NCT06438861
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This study aimed to see if adding the drug vibegron to standard Botox injections could better control urgent, frequent urination in women with overactive bladder that didn't improve with other treatments. The plan was to compare a group receiving Botox plus vibegron against a group receiving Botox plus a placebo. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.